miércoles, 18 de noviembre de 2026

Leukemia Vaccine Succeeds In Pivotal Trial

Leukemia Vaccine Succeeds In Pivotal Trial The trial showed a 41% reduction in risk of death for patients with acute myeloid leukemia who received the galinpepimut-S (GPS) vaccine, The Washington Post reported. Plus, the FDA anticipates the safety review of the abortion pill mifepristone to be finished by March. https://kffhealthnews.org/morning-breakout/pharma-and-tech-111826/

No hay comentarios: